Navigation Links
Publication in SLEEP Journal Demonstrates Positive Results of Large Multi-Center Clinical Trial for Provent® Sleep Apnea Therapy
Date:4/4/2011

BELMONT, Calif., April 4, 2011 /PRNewswire/ -- Ventus Medical, Inc. today reported positive results from a 19 center clinical trial using its FDA-cleared Provent® Sleep Apnea Therapy device to treat obstructive sleep apnea. Provent Therapy uses the patient's own breathing to create expiratory positive airway pressure (EPAP) to keep the airway open during sleep. The full results of this three month study were published in the April 2011 issue of the peer-reviewed medical journal SLEEP, an official publication of the American Academy of Sleep Medicine.

(Photo:  https://photos.prnewswire.com/prnh/20110209/SF45785-a)

(Photo:  https://photos.prnewswire.com/prnh/20110209/SF45785-b)

"This randomized, sham-controlled study demonstrates that Provent Therapy significantly improves the apnea hypopnea index (AHI), a scale to measure the number of breathing interruptions or stoppages per hour of sleep, as well as subjective sleepiness, as measured by the Epworth Sleepiness Scale (ESS) in patients with obstructive sleep apnea," said study author Richard B. Berry, M.D., professor of medicine at the University of Florida College of Medicine, medical director of the University of Florida and Shands Sleep Disorders Center, and former president of the American Sleep Medicine Foundation. "Importantly, self-reported patient adherence on Provent Therapy was almost 90 percent."

The prospective, double-blind, sham-controlled clinical study enrolled 250 patients diagnosed with obstructive sleep apnea at 19 academic and private sleep centers in the United States.  The primary endpoint of the study was the reduction in AHI.  In-laboratory polysomnography, a method of monitoring breathing disruptions during sleep, was performed at the start of the study and after three months of treatment.

<
'/>"/>
SOURCE Ventus Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Versatility of 454 Sequencing(TM) Demonstrated in Three Publications in Science Last Week
3. Medifast, Inc. Announces Acceptance for Publication of Clinical Efficacy Study
4. Halozyme Therapeutics Announces Peer-Reviewed Publications of the INFUSE-LR Clinical Trial Results and Clinical Practice Experience With Hylenex
5. PTC Therapeutics Announces Publication of Preclinical Data in PNAS
6. Pharmacyclics Announces Data and Publication Characterizing Highly-Selective HDAC Inhibitor
7. Micromet Announces the Publication of BiTE Antibody Review in Drugs of the Future
8. Industry Executives Finding Value in Shift of Scientific Publications
9. OPKO Health and Pathogenics Announce Data Publication Demonstrating the Potential Utility of NCT in a Severe Eye Infection
10. Sangamo BioSciences and Sigma-Aldrich Announce Publication of Study Demonstrating Zinc Finger Technology for Rapid Generation of Knock-Out Cell Lines
11. Bionovo Announces Publication of the Paper Detailing the Mechanism of Action of Its Cancer Drug BZL101
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... , Aug. 21, 2014  eRelevance Corporation ( ... announced today that it has completed integration with ... for Plastic Surgery and Dermatology practices. ... value to healthcare practices using Nextech," stated ... Corporation. "Using information from the EMR we are ...
(Date:8/21/2014)... /CNW/ - Eisai Limited is pleased to support the Canadian ... book available in Canada . The comic ... educate children and their parents about epilepsy, the most common ... than 300,000 Canadians. Eisai is guided by a corporate philosophy ... the patient is central – there was a need within ...
(Date:8/21/2014)... /PRNewswire-iReach/ -- Inc. magazine today ranked ... straight year, No. 349 in Health on its ... the nation,s fastest-growing private companies. The list represents ... segment of the economy—America,s independent entrepreneurs. Companies such ... Zillow, and many other well-known names gained early ...
Breaking Medicine Technology:eRelevance Corporation Integrates with Nextech Electronic Medical Records 2Eisai Pleased to Support Canadian Epilepsy Alliance Comic Book that Teaches Children About Epilepsy 2Carolina's HME Named for Third Straight Year to Inc. Magazine's List of America's Fastest-Growing Private Companies--the Inc. 5000 2Carolina's HME Named for Third Straight Year to Inc. Magazine's List of America's Fastest-Growing Private Companies--the Inc. 5000 3
... DIEGO, Jan. 10, 2011 Optimer Pharmaceuticals, Inc. (Nasdaq: ... Linda Amper, Ph.D., as Senior Vice President of Human ... Economics & Outcomes Research (HEOR), and John Womelsdorf, Ph.D., ... will strengthen the management team as the Company prepares ...
... Calif., Jan. 10, 2011 OncoMed Pharmaceuticals, Inc., ... today announced that patient dosing has commenced in a Phase ... tumor cancers.   OMP-59R5 is a monoclonal antibody ... to specifically block these targets to enter human studies.  The ...
Cached Medicine Technology:Optimer Pharmaceuticals Announces Key Additions to Management Team 2Optimer Pharmaceuticals Announces Key Additions to Management Team 3Optimer Pharmaceuticals Announces Key Additions to Management Team 4OncoMed Pharmaceuticals Initiates Phase 1 Clinical Trial of Anti-Cancer Stem Cell Therapeutic OMP-59R5 2OncoMed Pharmaceuticals Initiates Phase 1 Clinical Trial of Anti-Cancer Stem Cell Therapeutic OMP-59R5 3
(Date:8/22/2014)... patients who need surgery for facial pain caused by ... often used, reports a study in the September issue ... the Congress of Neurological Surgeons . The journal ... a part of Wolters Kluwer Health . , ... much lower cost than other types of surgical treatments ...
(Date:8/22/2014)... August 22, 2014 “Dr. Luciana Show – ... , aka Dr. Luciana, is finding it challenging to stay ... while taking care of hundreds of students, so the editing ... the show is completed, and she recently entered it into ... including those of her husband, actor/screenwriter Gregory Graham , ...
(Date:8/22/2014)... 22, 2014 The report "Higher ... Security & Compliance, Campus Technology, Student & Curriculum, ... (2014-2019)", defines and segments the global Higher Ed ... and forecasting of market sizes. The report also ... and opportunities impacting it along with the adoption ...
(Date:8/22/2014)... However, these are two entirely different mechanisms that occur ... digest lactose properly because they lack an enzyme known ... more dangerous cow milk allergy, however, the body,s immune ... , According to statistics, about two to three percent ... allergy. Less adults are diagnosed with the disease. The ...
(Date:8/22/2014)... August 22, 2014 This funding was ... research affiliate, Saneron CCEL Therapeutics, Inc. in the form ... is extremely pleased to collaborate with Saneron on several ... we hope will lead to regenerative therapies using ... as ALS,” David Portnoy, Chairman and Co-CEO of Cryo-Cell, ...
Breaking Medicine News(10 mins):Health News:More common procedures for painful facial tics carry high costs, reports study in Neurosurgery 2Health News:Professor Luciana Lagana Dedicates to Her CSUN Students the “Dr. Luciana Show-Aging and Falling” AOF Festival Nomination (Screening at Krikorian Monrovia Cinema on 08/25) 2Health News:Professor Luciana Lagana Dedicates to Her CSUN Students the “Dr. Luciana Show-Aging and Falling” AOF Festival Nomination (Screening at Krikorian Monrovia Cinema on 08/25) 3Health News:Professor Luciana Lagana Dedicates to Her CSUN Students the “Dr. Luciana Show-Aging and Falling” AOF Festival Nomination (Screening at Krikorian Monrovia Cinema on 08/25) 4Health News:Higher Education Market Worth $65.83 Billion by 2019 - New Report by MarketsandMarkets 2Health News:Higher Education Market Worth $65.83 Billion by 2019 - New Report by MarketsandMarkets 3Health News:Higher Education Market Worth $65.83 Billion by 2019 - New Report by MarketsandMarkets 4Health News:Scientists uncover why major cow milk allergen is actually allergenic 2Health News:Cryo-Cell Provides Funding for Cord Blood Clinical Trial Application to Treat ALS 2Health News:Cryo-Cell Provides Funding for Cord Blood Clinical Trial Application to Treat ALS 3
... psoriasis condition are more likely to smoke, and smoking contributes ... scaling of the skin, and affect places like legs, scalp, ... of the feet. The chances of people with psoriasis suffering ... published in the Archives of Dermatology. ,Data ...
... Co, known as MSD India, has entered into a collaboration ... studies on the former's investigational cervical cancer drug, Gardasil.// ... India. Under the agreement, clinical trials will be conducted for ... ,The vaccine that has been developed by Merck and ...
... Rutgers, The State University of New Jersey have come ... related to determining the quality of mate in humans.// ... in choosing mates among many animal species. Impressive dancers ... ,Rutgers in association with computer scientist at the University ...
... sitting or lying down is a treatable health problem, but ... ,The condition, called Restless Legs Syndrome (RLS), makes it ... long drives or even while watching a movie, say experts., ... which is accompanied in many cases by a tingling and ...
... Department of Health and Mental Hygiene (DOHMH) has banned at ... "dangerous levels" of lead and mercury. // , ,"Though ... Board of the Institute of Medicine of the National Academies ... ppm (parts per million) of lead and no more than ...
... we took note and took care of mother nature. ... USA.,It is called the Canon National Parks Science Scholars ... eight doctoral students -- from Canada to Chile, and ... are receiving significant multi-year scholarships this year to conduct ...
Cached Medicine News:Health News:Merck, ICMR to conduct joint trials on cervical cancer vaccine 2Health News:Shaking Legs Syndrome Is Curable 2Health News:NY Health Dept Bans 3 Ayurveda Drugs 2Health News:Time to wake up as conservationists 2Health News:Time to wake up as conservationists 3
0.2 mm hook with curved shaft to reach over lens optic. Flat serrated handle with polished finish. Overall length: 4.8 inches. Most popular size or model....
Angled 45 degrees, 10 mm shaft with 0.2 mm tip. Round knurled handle with dull finish. Overall length: 4.6 inches....
Straight 31 mm shaft with flat handle and polished finish. 0.5 mm cup. Overall length: 5 inches....
0.5 mm curette cup, reverse side of sandblasted to polish capsule. Round knurled handle with polished finish. Overall length: 5 inches....
Medicine Products: